NCT05706831

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of a musical interventionand non-invasive brain stimulation in neurological patients. The main questions it aims to answer are:

  • to evaluate the residual neuroplastic processes in DOC state related to music exposure
  • to determine the putative modulation of the aforementioned processes and the clinical outcome of DOC patients by non-pharmacological strategies, i.e., electric (tDCS) and music stimulation
  • to evaluate the impact of this intervention on caregiver's burden and psychological distress. Participants will be randomly assigned to one of three different music-listening intervention groups. Primary outcomes will be clinical, that is based on the neurologist's observations of clinical improvement, and neurophysiological, collected pre-intervention, post-intervention and post-placebo.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Sep 2022Dec 2026

Study Start

First participant enrolled

September 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 31, 2023

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 4, 2025

Status Verified

April 1, 2025

Enrollment Period

4.3 years

First QC Date

November 16, 2022

Last Update Submit

May 30, 2025

Conditions

Keywords

music stimulationtDCSAphasiaNeglectDOCStroke

Outcome Measures

Primary Outcomes (15)

  • Neuropsychological outcomes

    -Coma Recovery Scale-Revised (CRS-R) - (0-23). High score means a better outcome.

    Change from baseline Coma Recovery Scale- Revised at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Disability Rating Scale (DRS) - (0-29). High score means a worse outcome.

    Change from baseline Disability Rating Scale at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Rancho Levels of Cognitive Functioning (LCF) - (1-8). High score means a better outcome.

    Change from baseline Rancho Levels of Cognitive Functioning at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Glasgow Outcome Scale- Extended (GOS-E) - (1-8). High score means a better outcome.

    Change from baseline Glasgow Outcome Scale- Extended at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Aachener Aphasie Test (AAT). This test includes six subtests: spontaneous speech, token test, repetition, written language, naming, and comprehension. Spontaneous speech is structured in six parts (0-30). High score means a better performance; Token test is composed by 50 items; for the score the number of error id considered (0-50). Repetition sub test is composed by 50 items; for each item the score range from 0 to 3; high score means better outcome (0-150). Written language subtest is composed by 30 items; for each item the score range from 0 to 3; high score means better outcome (0-90). Naming subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120). Comprehension subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).

    Change from baseline Aachener Aphasie Test at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Italian version of Functional Outcome Questionnaire for Aphasie (FOQ-A) - (32-160). High score means a better outcome.

    Change from baseline Italian version of Functional Outcome Questionnaire for Aphasie at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Functional Assessment Measure - Cognitive subscale - (FAM) - (14-98); high score means a better outcome.

    Change from baseline Functional Assessment Measure - Cognitive subscale at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Quality of Life questionnaire for Aphasics (QLQA) - (0-148); High score means a better outcome.

    Change from baseline Quality of Life Questionnaire for aphasics at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    The semi-structured scale for functional evaluation of personal neglect - (0-9); High score means a worse outcome.

    Change from baseline The semi-structured scale for functional evaluation of personal neglect at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Barrage test (0-36). High score means a better outcome.

    Change from baseline Barrage Test at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Letter cancellation test - (0-104). High score means a better outcome.

    Change from baseline Letter cancellation test at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Sentence reading test (0-6). High score means a worse outcome.

    Change from baseline Sentence reading test at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    Wundt-Jastrow area illusion test (0-20). High score means a worse outcome.

    Change from baseline Wundt-Jastrow area illusion test at 2 weeks and 4 weeks

  • Neuropsychological outcomes

    The semi structured scale for the functional evaluation of extrapersonal neglect (0-9). High score means a worse outcome.

    Change from baseline The semi structured scale for the functional evaluation of extrapersonal neglect at 2 weeks and 4 weeks

  • Neurophysiological outcome

    The ratio of fast (8-30 Hz, α-β) to slow (2-8 Hz, δ-θ) oscillation amplitude at the midline electrodes (Fz, Cz, Pz, Oz) will be measured and compared pre- and post intervention."

    Change from baseline oscillation at 2 weeks and 4 weeks

Secondary Outcomes (6)

  • Caregiver psychological distress

    Change from baseline Back depression Inventory II at 2 weeks and 4 weeks

  • Caregiver psychological distress

    Change from baseline State-trait anxiety inventory; at 2 weeks and 4 weeks

  • Caregiver psychological distress

    Change from baseline Questionario psicofisiologico (CBA) at 2 weeks and 4 weeks

  • Caregiver psychological distress

    Change from baseline Prolonged grief disorder -12 at 2 weeks and 4 weeks

  • Caregiver psychological distress

    Change from baseline Family strain questionnaire at 2 weeks and 4 weeks

  • +1 more secondary outcomes

Study Arms (3)

Group 1

EXPERIMENTAL

Group 1 will receive tEs combined with music stimulation for 2 weeks, 1 week of wash out, then sham stimulation combined with noise (placebo) for other 2 weeks.

Other: Combinatory effect of music stimulation and neurostimulation

Group 2

EXPERIMENTAL

Group 2 will receive sham stimulation and noise (placebo) for the first 2 weeks, then 1 week wash out, and finally tEs and music stimulation for other 2 weeks.

Other: Combinatory effect of music stimulation and neurostimulation

Group 3

EXPERIMENTAL

Group 3 will receive only music stimulation and sham stimulation for 2 weeks, 1 week of wash out, then sham stimulation and noise (placebo) for another 2 weeks.

Other: Combinatory effect of music stimulation and neurostimulation

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Post-stroke aphasia
  • Post-stroke neglect
  • Patients with disorders of consciusness (DOC)

You may not qualify if:

  • No auditory injury
  • no hystory of neurological disease
  • No hystory of psychiatric disease
  • Previous stroke
  • use of alcohol and drugs
  • premorbid dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituti Clinici Scientifici Maugeri

Bari, Ba, 70025, Italy

RECRUITING

Related Publications (1)

  • Spaccavento S, Carraturo G, Brattico E, Matarrelli B, Rivolta D, Montenegro F, Picciola E, Haumann NT, Jespersen KV, Vuust P, Losavio E. Musical and electrical stimulation as intervention in disorder of consciousness (DOC) patients: A randomised cross-over trial. PLoS One. 2024 May 31;19(5):e0304642. doi: 10.1371/journal.pone.0304642. eCollection 2024.

MeSH Terms

Conditions

Consciousness DisordersStrokeAphasia

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesSpeech DisordersLanguage DisordersCommunication Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three groups of neurological patients will be considered for the study. For each group, participants will be randomly allocated to one of three intervention groups. These interventions will consist of a combination of musical stimulation, sham stimulation, tDCS and noise.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 16, 2022

First Posted

January 31, 2023

Study Start

September 1, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 4, 2025

Record last verified: 2025-04

Locations